(Total Views: 509)
Posted On: 02/04/2021 1:20:41 AM
Post# of 148925
Re: Goosebumps #76154
Goosebumps,
June 11 PR that CD10 reached enrollment goal (14 day trial period)
https://www.cytodyn.com/investors/news-events...2-covid-19
June 25 CD10 complete.
July 21 PR stating
This was the account of the reduced SAEs vs. placebo.
https://www.cytodyn.com/investors/news-events...ns-phase-2
So data verification, database lock and the preliminary analysis completed within 30 days.
I'm holding out hope for this week, especially after discussion of data unblinding in call to Filipino physicians last week.
June 11 PR that CD10 reached enrollment goal (14 day trial period)
Quote:
CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next
https://www.cytodyn.com/investors/news-events...2-covid-19
June 25 CD10 complete.
July 21 PR stating
Quote:
Impressive Results From CytoDyn’s Phase 2 COVID-19 Trial
This was the account of the reduced SAEs vs. placebo.
https://www.cytodyn.com/investors/news-events...ns-phase-2
So data verification, database lock and the preliminary analysis completed within 30 days.
I'm holding out hope for this week, especially after discussion of data unblinding in call to Filipino physicians last week.
(3)
(0)Scroll down for more posts ▼
